Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

Immunology and Microbiology

• Immunodeficiency 100%
• Lower Respiratory Tract 66%
• Respiratory Syncytial Virus 66%
• Transplantation 50%
• High Risk Population 50%
• Human Respiratory Syncytial Virus 50%
• Cells 50%
• Mortality 50%
• Ribavirin 33%
• Upper Respiratory Tract 16%
• Respiratory Syncytial Virus Infection 16%
• Incidence 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Immune Deficiency 100%
• Lower Respiratory Tract Infection 66%
• Human Respiratory Syncytial Virus 50%
• Mortality 50%
• Infection 33%
• Ribavirin 33%
• Antiviral Therapy 33%
• Respiratory Syncytial Virus Infection 16%
• Upper Respiratory Tract Infection 16%
• Incidence 16%
• Death 16%